Xvivo Perfusion AB
XVIVO.ST
#5458
Rank
HK$7.84 B
Marketcap
HK$248.91
Share price
2.87%
Change (1 day)
-7.87%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): HK$28.08 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are HK$73.21 Million. In 2023 the company made an earning of HK$2.45 Million a decrease over its 2022 earnings that were of HK$17.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$28.08 M1042.24%
2023 HK$2.45 M-86.2%
2022 HK$17.81 M226.49%
2021 HK$5.45 M-110.72%
2020 -HK$50.92 Million-1221.07%
2019 HK$4.54 M-70.61%
2018 HK$15.45 M117.32%
2017 HK$7.1 M146.09%
2016 HK$2.88 M-61.52%
2015 HK$7.5 M-3.88%
2014 HK$7.81 M-39.59%
2013 HK$12.93 M